Sequent Scientific Limited

NSE SEQUENT.NS

Sequent Scientific Limited Free Cash Flow Yield on January 14, 2025: -0.01%

Sequent Scientific Limited Free Cash Flow Yield is -0.01% on January 14, 2025, a 99.75% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Sequent Scientific Limited 52-week high Free Cash Flow Yield is -0.00% on September 30, 2024, which is 40.00% above the current Free Cash Flow Yield.
  • Sequent Scientific Limited 52-week low Free Cash Flow Yield is -2.36% on March 26, 2024, which is -47,160.00% below the current Free Cash Flow Yield.
  • Sequent Scientific Limited average Free Cash Flow Yield for the last 52 weeks is -0.43%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
NSE: SEQUENT.NS

Sequent Scientific Limited

CEO Mr. Rajaram Narayanan
IPO Date March 10, 2016
Location India
Headquarters Dosti Pinnacle
Employees 1,195
Sector Health Care
Industries
Description

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.

Similar companies

SYNGENE.NS

Syngene International Limited

USD 9.56

0.73%

SOLARA.NS

Solara Active Pharma Sciences Limited

USD 7.64

4.37%

INDOCO.NS

Indoco Remedies Limited

USD 3.76

0.04%

LAURUSLABS.NS

Laurus Labs Limited

USD 6.56

1.75%

HIKAL.NS

Hikal Limited

USD 4.21

4.98%

StockViz Staff

January 15, 2025

Any question? Send us an email